Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
Antonio Vena, Marco Berruti, Andrea Adessi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2780-2780
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community
Edward Goldstein, Marc Lipsitch, Müge Çevik
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 3, pp. 362-369
Open Access | Times Cited: 336
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
Chih-Cheng Lai, Jui-Hsiang Wang, Po‐Ren Hsueh
International Journal of Infectious Diseases (2020) Vol. 101, pp. 314-322
Open Access | Times Cited: 210
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland
Luca Piccoli, Paolo Ferrari, Giovanni Piumatti, et al.
The Lancet Regional Health - Europe (2020) Vol. 1, pp. 100013-100013
Open Access | Times Cited: 84
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 79
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 72
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 53
RETRACTED AND REPLACED: Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis
Mackenzie E. Hannum, Riley J Koch, Vicente A Ramirez, et al.
Chemical Senses (2022) Vol. 47
Open Access | Times Cited: 47
COVID-19 prevalence and mortality in longer-term care facilities
Andrew Levin, Juulia Jylhävä, Dorota Religa, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 227-234
Open Access | Times Cited: 38
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies
John P. A. Ioannidis
BMJ evidence-based medicine (2022) Vol. 27, Iss. 6, pp. 324-329
Open Access | Times Cited: 37
Are People Optimistically Biased about the Risk of COVID-19 Infection? Lessons from the First Wave of the Pandemic in Europe
Kathleen McColl, Marion Debin, Cécile Souty, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 436-436
Open Access | Times Cited: 48
Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review
Andrea Boscutti, Giuseppe Delvecchio, Alessandro Pigoni, et al.
Brain Behavior & Immunity - Health (2021) Vol. 15, pp. 100268-100268
Open Access | Times Cited: 43
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico
Ana Basto‐Abreu, Martha Carnalla, Leticia Torres‐Ibarra, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis
Mackenzie E. Hannum, Riley J Koch, Vicente A Ramirez, et al.
Chemical Senses (2023) Vol. 48
Open Access | Times Cited: 15
Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
Shay Reicher, Ronit Ratzon, Shay Ben-Sahar, et al.
European Journal of Epidemiology (2021) Vol. 36, Iss. 7, pp. 727-734
Open Access | Times Cited: 39
Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
John P. A. Ioannidis
BMJ Global Health (2021) Vol. 6, Iss. 1, pp. e004614-e004614
Open Access | Times Cited: 34
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
Scandinavian Journal of Public Health (2021) Vol. 50, Iss. 1, pp. 124-135
Open Access | Times Cited: 34
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study
Francisco Javier Candel, Pablo Barreiro, Jesús San Román, et al.
Age and Ageing (2021) Vol. 50, Iss. 4, pp. 1038-1047
Open Access | Times Cited: 31
The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review
Natasha Marcella Vaselli, Daniel Hungerford, B. Shenton, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0250541-e0250541
Open Access | Times Cited: 29
Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021
Takahiro Sanada, Tomoko Honda, Fumihiko Yasui, et al.
Journal of Epidemiology (2021) Vol. 32, Iss. 2, pp. 105-111
Open Access | Times Cited: 25
Occupational Exposure in the Lombardy Region (Italy) to SARS-CoV-2 Infection: Results from the MUSTANG–OCCUPATION–COVID-19 Study
Paola Della Valle, Marco Fabbri, Fabiana Madotto, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 5, pp. 2567-2567
Open Access | Times Cited: 24
COVID-19 seroprevalence in Pakistan: a cross-sectional study
Ahsan Maqbool Ahmad, Khurram Shahzad, Mariumn Masood, et al.
BMJ Open (2022) Vol. 12, Iss. 4, pp. e055381-e055381
Open Access | Times Cited: 17
Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic
Maher A. Sughayer, Asem Mansour, Abeer Al Nuirat, et al.
International Journal of Infectious Diseases (2021) Vol. 107, pp. 116-120
Open Access | Times Cited: 22
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Aude Richard, Ania Wisniak, Javier Perez‐Saez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 21
Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
Francesco Napolitano, Gabriella Di Giuseppe, Maria Vittoriå Montemurro, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 9, pp. 4761-4761
Open Access | Times Cited: 19
Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study
Manola Comar, Simone Benvenuto, Marzia Lazzerini, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2021) Vol. 47, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top